Full
Outline
To investigate the role and primary mechanism of a novel fusion gene RELCH-RET in driving the malignant transformation of normal human bronchial epithelial (HBE) cells.
Based on retrospective clinical data from 456 non-small cell lung cancer (NSCLC) patients admitted in the Second Affiliated Hospital of Army Medical University from January 2019 to June 2022, a fusion gene, RELCH-RET,was identified as a research target. Three cell models were established: negative control (HBE VC, transfected with empty lentiviral vector), RET control (HBE RET, transfected withlentiviral overexpression vector of Flag-RET), and experimental group (HBE RELCH-RET, transfected with lentiviral overexpression vector of Flag-RELCH-RET). MTS assay and Transwell assay were used to detect cell proliferation and migratory and invasive abilities. In vivo tumorigenicity of the 3 cell models was assessed in 15 female non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice (SPF grade, 4 weeks old, weighing 15.1±0.4 g) via subcutaneous xenograft experiments, with 5 animals in each group. Western blotting was employed to detect the autophosphorylation of RET (Y905) and the phosphorylation of downstream signaling proteins ERK1/2, EGFR (Y845) and STAT3 (Y705). Dimerization and multimerization status of RELCH-RET were analyzed by chemical cross-linking (DTME treatment) in combination with Western blotting, with the reversibility being confirmed through de-cross-linking experiments.
There were 3 cases carrying RELCH-RET fusion gene screened out from the 469 NSCLC patients. Compared with the HBE VC and HBE RET groups, the HBE RELCH-RET group exhibited significantly enhanced cell proliferation (P<0.01), and acquired migratory and invasive abilities (P<0.01), while the control groups did not demonstrate the abilities. In the mouse xenograft tumor model, HBE cells stably expressing RELCH-RET developed significant tumor nodules (P<0.001), whereas the control groups (empty vector and wild-type RET) failed to exhibit detectable tumor growth. Western blotting revealed that RELCH-RET could induce the autophosphorylation of the RET tyrosine residue (Y905) and significantly up-regulate the phosphorylation levels of ERK1/2, EGFR (Y845), and STAT3 (Y705) proteins. Chemical cross-linking combined with Western blot analysis demonstrated that RELCH-RET formed a dimer (~170 kDa) in HBE cells, which is reversibly dissociated into monomers upon decross-linking treatment.
The novel fusion gene RELCH-RET, promotes ligand-independent dimerization/oligomerization, thereby mediating RET autophosphorylation, subsequently activates the downstream typical RET signaling pathway and ultimately drives the malignant transformation of normal HBE cells.
7
2
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |
关闭全屏
No. 86 Xueyuan South Road, Haidian District, Beijing
010-62662699(Operation and Technical Support)
qkjq@cast.org.cn
Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House
